菌体的药理动力学研究在感染的体外药理动力学模型中
M L G Attwood1, Pippa Griffin1, Patryk Smorowinski1
1Bristol Centre for Antimicrobial Research & Evaluation (BCARE), Severn Infection Sciences, Pathology Sciences Building, North Bristol NHS Trust, Southmead Hospital, Westbury-on-Trym, Bristol BS10 5NB, UK.
JAC-antimicrobial resistance
|December 1, 2025
概括
菌体治疗是抗生素的一个有希望的替代品. 这项研究表明,体外模型可以预测菌体如何对抗大肠杆菌,有助于临床使用和试验设计.
科学领域:
- 微生物学 微生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 抗菌素耐药性需要替代治疗方法,如菌体治疗.
- 了解菌体的药理动力学/药理动力学 (PK/PD) 对临床应用至关重要,但缺乏足够的工具.
- 目前的局限性阻碍了个别患者的治疗和菌体治疗的临床试验设计.
研究的目的:
- 使用体外模型评估菌体尾酒对*大肠杆菌*菌株的抗菌疗效.
- 评估菌体的药理动力学 (PD) 和它们与细菌群的相互作用.
- 确定体外模型对预测菌体PK/PD和为人类剂量提供信息的有用性.
主要方法:
- 使用传统的PK/PD评估工具.
- 在48小时内执行时间杀死曲线 (TKC),以评估最初的抗菌作用.
- 在72小时内使用稀释体外模型 (IVM) 进行全面的PD分析.
主要成果:
- *大肠杆菌*菌株对TKC中的菌体暴露表现出不同的反应,具有明显的杀死和再生模式.
- IVM证实了这些细菌PD模式,显示了菌体位和细菌数量之间的反相关性.
- 菌体数量随着细菌的杀死而持续增加,表明有效的菌体活动.
结论:
- 一个体外稀释模型有效地研究菌体尾酒对大肠杆菌的疗效,适应菌株变异.
- 这个模型提供了细微的菌体PK/PD数据.
- 这些发现提供了翻译相关的信息,用于优化菌体治疗中人类剂量策略.
更多相关视频
相关概念视频
Lytic Cycle of Bacteriophages
77.3K
Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the...
77.3K
DNA Bacteriophages
758
Bacteriophages, or phages, are viruses that specifically infect bacteria, utilizing their genetic material to hijack host cellular machinery for replication. DNA bacteriophages employ single-stranded DNA (ssDNA) or double-stranded DNA (dsDNA) genomes. These phages exhibit diverse replication strategies and host interactions, influencing their ecological roles and applications in biotechnology and medicine.ssDNA BacteriophagesssDNA phages, with their small genomes, utilize unique strategies to...
758
Viral Replication: Lytic Cycle
1.1K
Bacteriophages, or phages, are viruses that specifically infect bacteria. Among them, T-even bacteriophages, such as T4, exhibit a well-characterized lytic replication cycle in Escherichia coli (E. coli). This process ensures the rapid proliferation of the virus while ultimately leading to the destruction of the bacterial host.Attachment and DNA InjectionThe infection process begins with the recognition and binding of the T4 phage to the E. coli cell surface. Tail fibers of the phage...
1.1K
Pharmacokinetic Models: Overview
1.8K
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
1.8K
Lysogenic Cycle of Bacteriophages
67.3K
In contrast to the lytic cycle, phages infecting bacteria via the lysogenic cycle do not immediately kill their host cell. Instead, they combine their genome with the host genome, allowing the bacteria to replicate the phage DNA along with the bacterial genome. The incorporated copy of the phage genome is called the prophage. Some prophages can re-activate and enter the lytic cycle. This often occurs in response to a perturbation, such as DNA damage, but can also transpire in the absence of...
67.3K
Model Approaches for Pharmacokinetic Data: Physiological Models
236
Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
236


